218,00 € excl.VAT – 405,00 € excl.VAT
This antibody reacts with the CD28-antigen, which is expressed on approximately 29 % of CD4+. CD28 mediates cell adhesion trough the two ligands, CD80, expressed on activated B cells. Cross-blooking of CD28 induces T cell activation, suggesting an important role for CD28 in the interaction between B and T cells. This antibody recognizes an homodimeric transmembrane glycoprotein present on most mature T cells, thymocytes and plasma cells.
| Conjugated | |
|---|---|
| Size | |
| Regulatory Status | |
| Clone | |
| Gene ID | |
| Format | |
| Species Reactivity | |
| Isotype | |
| Tested Applications | |
| Clonality | |
| UniProt | |
| Mw | |
| Population | |
| Volumen/test | |
| Storage | Store in the dark at 2-8°C. |
| Other names | T44, Tp44, T-cell-specific surface glycoprotein CD28. |
| Buffer | The reagent is provided in aqueous buffered solution containing protein stabilizer, and ≤0.09% sodium Azide (NaN3). |
| Immunogen | Human CD28 Transfected Cell Line. |
| Concentration | 0,05 mg/ml |
CD28, clone CD28.2, is a mAb intended for identification/enumeration of human T cells subsets by FCM. This reagent is effective for direct IF staining of human tissue for FCM analysis using ≤1 μg/10^6 cells.
Technical Data Sheet (TDS) – (English). Safety Sheet (MSDS) – (English)
| Product description | Reference | Title | Authors | Journal | Year | |
|---|---|---|---|---|---|---|
| Product description | Reference | Title | Authors | Journal | Year |